Thromboembolic disease in pregnancy.

Area of Science:

• Obstetrics and Gynecology
• Hematology
• Reproductive Medicine

Background:

• Recent publications offer updated estimates for pregnancy-related venous thromboembolic disease incidence.
• Growing evidence suggests a link between inherited thrombophilias and adverse pregnancy outcomes, including fetal loss.
• The optimal use of thromboprophylaxis during pregnancy requires further investigation.

Purpose of the Study:

• To review current estimates of pregnancy-related venous thromboembolic disease.
• To highlight the association between inherited thrombophilias and pregnancy complications.
• To identify the need for evaluating the risk-benefit balance of thromboprophylaxis in clinical practice.

Main Methods:

• Literature review of recent publications on venous thromboembolic disease in pregnancy.
• Analysis of studies investigating inherited thrombophilias and pregnancy outcomes.
• Synthesis of evidence regarding thromboprophylaxis efficacy and safety.

Main Results:

• New estimates for the incidence of pregnancy-related venous thromboembolic disease are available.
• Evidence increasingly supports an association between inherited thrombophilias and pregnancy complications, including fetal loss.
• The risk-benefit profile of thromboprophylaxis in pregnancy is not yet fully established.

Conclusions:

• Further research is essential to establish a robust evidence base for clinical decisions regarding thromboprophylaxis in pregnancy.
• Understanding the interplay between inherited thrombophilias and pregnancy complications is crucial.
• Clinical practice guidelines for managing venous thromboembolic disease risk in pregnancy need further development.